Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2026 05:00 ET | Source: AKAMPION

EMA Grants PRIME Designation to TolerogenixX’s MIC-Lx Therapy for Donor-Specific Immune Tolerance in Kidney Transplantation

TolerogenixX´ MIC therapy receives EMA PRIME designation; up to 10-year follow‑up data support sustained safety and reduced immunosuppression